Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026?
Health & MedicineOne-Off3mFutuurDados de resolução verificadosProbabilidade implícita atualNão 90%
Qualidade do mercado
31 / 100
Baixa qualidadeVolume 24h
—
Liquidez
219,8 €
Baixa liquidezTraders
9
Comentários
1
Dados do mercado
Atualizado há 1 minuto
Tendências
Mercados Relacionados
Perguntas relacionadas para dar contexto, não uma comparação de contratos equivalentes.
Will Artificial blood be considered safe and effective for patients in Japan by the end of 2026?
FutuurWill cold showers be shown to be an effective treatment for depression by 2030
Manifold MarketsWill there be any genetic modification which substantially reduces suffering in vertebrates by end of 2026?
Manifold MarketsPreimplantation genetic diagnosis liberalised in Germany before 2027?
Manifold MarketsWill the FDA approve a psilocybin treatment during 2026?
FutuurEbola pandemic in 2026?
PolymarketRegras
Os critérios de resolução ainda não estão disponíveis para este mercado. Esta seção será preenchida nas próximas atualizações quando as regras da fonte forem armazenadas.
Mercados abertos
Health & MedicinePOLYMARKETHantavirus pandemic in 2026?
- No-0.1pt97%
- Yes+0.1pt3%
- Volume total
- € 15,6 mi
- Volume 24h
- € 18,3 mil
KALSHIWill WHO declare Hantavirus a Public Health Emergency of International Concern this Year?
- No96%
- Yes+1.9pt4%
- Volume total
- € 1,6 mi
- Volume 24h
- € 5,2 mil
KALSHIWhen will Intellia Therapeutics submit a BLA for Lonvo-z?
- before October+64.0pt98%
- before 2027+22.0pt98%
- before December+30.0pt98%
+3 mais resultados
POLYMARKETFDA approves skin cancer vaccine by which date?
- December 31,+6.0pt65%
- September+2.0pt41%
- June28%
- Volume total
POLYMARKETNew pandemic in 2026?
- No+0.5pt94%
- Yes-0.5pt6%
- Volume total
- € 916 mil
- Volume 24h
- € 1,5 mil
KALSHIMeasles cases in 2026?
- Above 300099%
- Above 400097%
- Above 6000-2.0pt57%
+2 mais resultados
- Volume total
- € 863,6 mil
- Volume 24h
- € 1 mil
- Ebola pandemic in 2026?
- Will 3 mg THC beverages be federally legal to sell?
- Ebola pandemic in 2026?
- Measles cases in U.S. in 2026?
- FDA decision: Bepirovirsen by GlaxoSmithKline (in 2026)
- When will Heidi Overton be confirmed as Commissioner of the FDA?
- What will the average number of measles cases be during Trump's term?
- Will the FDA approve any psychedelic substance for medical use this year?
- When will the FDA reclassify BPC-157 to Category 1?
- FDA decision: Saroglitazar by Zydus Therapeutics (in 2026)
- Will the FDA approve CagriSema?
Perguntas frequentes
- Quais são as probabilidades atuais de Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026??
- A Futuur cota No em 90% em 8 de setembro de 2026.
- Quando Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026? é resolvido?
- Bumetanide considered effective in the treatment of genetic Alzheimer's by the end of 2026? deverá ser resolvido em 31 de dezembro de 2026.